Mesenteric Ischemia Markers Study

Recruiting now · Not applicable

Conditions studied: Mesenteric Vascular Disease

In brief

Vascular bowel disease remains a socially significant and potentially fatal condition (if it develops into AMI), primarily due to delayed diagnosis. Blood biomarkers are theoretically ideal for early risk stratification (like troponins in myocardial infarction). However, the existing evidence base is characterized by low quality and high heterogeneity, which hinders their use in clinical practice. Therefore, there is an urgent and unmet clinical need for high-quality, methodologically rigorous research to validate biomarkers in MI. A current study (MESMARK) is to be undertaken to identify combinations of biomarkers that can reliably identify mesenteric ischemia (MI) and distinguish between non-transmural and transmural clinical relevant ischemia.

Key facts

Study ID

NCT07460700

Run by

Belarusian State Medical University

People needed

120

Starts

2025-12-22

Expected to finish

2026-12-12

Last updated by the study team

2026-03-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 18 years or older, all sex
• Initial decision, the presence of angio-visualisation of the MA and suspicion of mesenteric arteries diseases
• Patient's consent to participate in the study
• No pregnancy, no history of major operations on MA, the gastrointestinal tract and digestive organs (except appendectomy, endoscopic polypectomy).

You may not qualify if…

• Consent declined by patient or relatives
• Failure to meet inclusion criteria

Where it is running

• Belarusian State Medical University — Minsk, Belarus (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.